Adenosine 5′-triphosphate (ATP) is a coenzyme that functions in the transfer of chemical energy in the cell. In addition to its central role in facilitating cellular energetics, ATP is also thought to be one of the most primitive and widespread extracellular signaling molecules in bacterial, fungal, plant, and animal taxa ([@bib8]). Purinergic signaling by extracellular ATP plays roles in diverse physiological processes including cell proliferation, development, neurotransmission, and motility. In animals, many of these functions are mediated through vesicular ATP secretion and ATP-binding to purinergic receptors on target cells ([@bib6], [@bib7]). Nineteen purinergic receptors have been described in mammals and they regulate processes as varied as neuronal-glial signaling, platelet activation, and insulin secretion ([@bib1]; [@bib16]). Robust glucose-dependent ATP efflux has been observed in *Saccharomyces cerevisiae* and has been shown to occur through a vesicular pathway ([@bib5]; [@bib37]). However, yeast do not appear to have homologs of mammalian purinergic receptors and the biological functions of ATP efflux in *S. cerevisiae* have yet to be established. It has been reported that secretion of purines has a role in synchronizing sporulation among cells in yeast cultures, suggesting a primitive role for purines in cell-cell communication ([@bib18]).

A yeast study identified the transmembrane protein [Mcd4](http://www.yeastgenome.org/locus/S000001648/overview) as critical for ATP uptake into the secretory pathway ([@bib37]). This work demonstrated that inhibition or mis-sorting of the vacuolar H^+^-ATPase (vATPase) reduces Golgi levels and extracellular efflux of ATP ([@bib37]). These observations support the idea that ATP secretion occurs via vesicle-mediated mechanisms and that uptake of ATP into the secretory pathway happens upstream of the Golgi requiring a proton gradient. These ideas were later confirmed by studies in mammalian cells ([@bib16]). The late endosome is a critical organelle involved in sorting and trafficking proteins between the Golgi, cell membrane, and vacuole ([@bib27]). Over 60 yeast mutants interfering with late endosomal trafficking have been identified and grouped into five classes based upon endosomal morphology. These loss-of-function mutations result in a wide range of cellular consequences including transcription defects, vacuolar dysfunction, and secretion deficiencies ([@bib4]; [@bib34]). These pleiotropic effects demonstrate the broad role played by the late endosome in cellular processes that require vesicle trafficking.

To gain an in-depth understanding of the cellular mechanisms regulating ATP secretion, we performed a genomic screen to identify genes that modify this process in *S. cerevisiae*. In this screen, we measured extracellular ATP levels in stationary cell cultures in all strains in a complete yeast deletion library. Because deletion strains in the library have different growth rates, ATP measurements were performed in stationary cultures (30 hr postinoculation) in order to allow all deletion strains to reach comparable cell densities at the time of the assay. Our results identified several cellular components, including genetically intact mitochondria, as critical to maintaining wild-type extracellular ATP levels. We also found vesicle sorting to the late endosome as a significant regulator of extracellular ATP. Additionally, we discovered that the amino acid sensing EGO complex, the TORC1 kinase, and retrograde signaling all had significant effects on extracellular ATP levels. We postulate that this represents a central conserved nutrient-responsive and mitochondrial quality control pathway that regulates ATP production and efflux. Our study represents a significant advance toward understanding the relationship between extracellular ATP and nutrient signaling in yeast. More broadly, our work can be used to further studies aimed at understanding conserved signaling pathways and mechanisms regulating ATP secretion in higher eukaryotes.

Materials and Methods {#s1}
=====================

Yeast strains and methods {#s2}
-------------------------

A S288C homozygous deletion library (Open Biosystems, V1.0) was used for the primary screen and follow-up experiments using specific deletion strains. Retests were compared to the isogenic parent strain; BY4743 (*MATa/*α, *[ura3](http://www.yeastgenome.org/locus/S000000747/overview)*Δ*0/[ura3](http://www.yeastgenome.org/locus/S000000747/overview)*Δ*0*, *[leu2](http://www.yeastgenome.org/locus/S000000523/overview)*Δ*0/[leu2](http://www.yeastgenome.org/locus/S000000523/overview)*Δ*0*, *[his3](http://www.yeastgenome.org/locus/S000005728/overview)*Δ*0/[his3](http://www.yeastgenome.org/locus/S000005728/overview)*Δ*0*, *[LYS1](http://www.yeastgenome.org/locus/S000001473/overview)/[lys1](http://www.yeastgenome.org/locus/S000001473/overview)*Δ*0*, *[met15](http://www.yeastgenome.org/locus/S000004294/overview)*Δ*0/[MET15](http://www.yeastgenome.org/locus/S000004294/overview)*, *xxx*::*KanMX/xxx*::*KanMX)*. Rapamycin (Sigma) stocks were dissolved in DMSO and diluted to final concentration in growth media.

Primary ATP efflux screen and data analysis {#s3}
-------------------------------------------

The deletion library was replicated by inoculation into 96-well plates using a BioMek liquid-handling robot (Perkin Elmer) and grown in 150 μl YPD media (1% yeast extract, 2% bacto peptone, 2% glucose) to saturation at 30° for 48 hr. For the ATP assay, yeast cultures from each plate were replicated by 50-fold dilution into three fresh media plates resulting in three biological replicates of each deletion strain. Assay plates were grown in synthetic complete media (0.67% yeast nitrogen base with ammonium sulfate, 0.156% amino acids, 2% glucose) at 30° for 30 hr. Optical density at 660 nm (OD~660~) was measured from a 1:10 dilution in water in 96-well plates using a VictorX3 plate reader (Perkin Elmer). Additional control plates carrying appropriately diluted medium were measured as blanks (n = 8). Extracellular ATP levels present in each culture well were determined using the ATPlite assay (Perkin Elmer) according to the manufacturer's instructions. Briefly, the cultures in the undiluted assay plates were cleared by centrifugation and 50 μl of supernatant, 50 μl of mammalian lysis buffer, and 50 μl ATPlite-substrate were mixed and shaken at 750 rpm for 5 min. Luminescence (LUM) of each well was read at 420 nm in a VictorX3 plate reader.

Optical density (OD~660~) values outside of the experimentally derived linear range of the plate reader were excluded from subsequent analysis. Well-specific background OD~660~ absorbance readings were determined by individually averaging values generated in each well among the control plates. These well-specific OD~660~ values were then subtracted from the relative OD~660~ readings based on well position. LUM readings were then divided by background-subtracted OD~660~ values to determine the relative luminescence units per cell (RLU), which are reported as a log2 values. RLU measurements were normalized for plate effects by subtracting the mean of the log2 RLU ratios over all plates for the same well.

Retesting of selected mutants {#s4}
-----------------------------

Selected strains were streaked from the homozygous deletion library onto YPD plates. Isogenic parent strain and selected mutant strains were inoculated from single colonies into 200 μl liquid cultures of synthetic complete media in a 96-well plate (n = 6), grown for 48 hr, and diluted 50-fold to an assay plate. Assay plates were grown for 30 hr and extracellular ATP was measured as described above. Background LUM and OD~660~ values were subtracted from relevant measurements and retest data are reported relative to values for the parent strain (BY4743). For rapamycin studies, assay plates with parent strain cultures were grown for 26 hr, treated with rapamycin (Sigma) dissolved in DMSO or an equal volume of DMSO alone for 4 hr, and assayed as described. For time-course studies, six biological replicates of each strain were grown and assayed over a 96-hr period for ATP levels as described. Cells inoculated immediately before assay ('0 hr'), were used to derive assay background levels. Calculated ATP levels are reported relative to background and a student's *t*-test determined the significance of differences within each time-point compared to the parent strain.

Gene ontology analysis {#s5}
----------------------

Enrichment of gene ontology (GO) terms for strains with extreme levels of extracellular ATP (top and bottom 5%) was analyzed using the *GO Term Finder (v.0.83)* tool available through the *Saccharomyces Genome Database* website, <http://www.yeastgenome.org/cgi-bin/GO/goTermFinder.pl> ([@bib14]). GO analysis used all genes present in the deletion library as a background, a 0.01 p-value cutoff, and default settings. Enriched terms were parsed for redundancy using GO trimmer ([@bib19]) and remaining significant terms with a \>2-fold enrichment are reported.

Network analysis and visualization {#s6}
----------------------------------

Strains with extreme levels of extracellular ATP (top and bottom 5%) were anchored to the full functional interaction network YeastNet v.2 (<http://www.inetbio.org/yeastnet/>). YeastNet is comprised of 5483 proteins and 102,803 interactions derived from gene coexpression, genetic and physical protein interactions, literature and comparative genomics methods ([@bib22]). Nodes of the two groups (High and Low ATP) were extracted from the full network into two subnetworks with only their direct interactions. Only those networks with \>5 nodes are shown. GO annotations and respiratory mutants were included as node attributes.

Results and Discussion {#s7}
======================

A genomic screen identifies pathways that regulate extracellular ATP levels {#s8}
---------------------------------------------------------------------------

To identify genes that influence ATP efflux from yeast, we measured the extracellular ATP concentration in stationary culture medium for all the 5109 strains in the yeast homozygous deletion library. We reasoned that identifying mutants with particularly high or low levels of extracellular ATP would elucidate the signaling pathways and cellular components that regulate ATP secretion from eukaryotic cells. An initial experiment indicated that extracellular ATP in wild-type (BY4743) yeast grown in complete synthetic media with 2% glucose peaked at a concentration of approximately 1--2 μM by 40 hr postinoculation (data not shown). This ATP concentration is consistent with published observations for yeast grown in glucose ([@bib5]). The homozygous deletion library was grown in triplicate in synthetic complete media (2% glucose) for 30 hr (± 1 hr) at 30°. Cell densities were measured as optical density at 660 nm and ATP concentrations in the cleared media was measured using a luciferase-based luminescence assay. Strains whose optical densities were below the linear range of our instrument in two of three biological replicates (*i.e.*, slow growing deletions) were excluded from further analysis. After correction for plate position effects, normalized luminescence and OD readings were used to determine the average ratio of luminescence to cell density for each deletion strain. This is henceforth referred to as extracellular ATP levels. Of the 5109 samples in the homozygous deletion collection, we were able to accurately determine the relative extracellular ATP levels for 4609 of the 5109 deletion strains in the library ([Figure 1](#fig1){ref-type="fig"} and Supporting Information, [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). To identify pathways that influence extracellular ATP levels, we ranked strains by their extracellular ATP level and selected the upper and lower 5% of the distribution (n = 230) to represent the strains with extreme high and low ATP efflux ([Figure 1](#fig1){ref-type="fig"} and [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). These two groups are referred to as High and Low Extracellular ATP groups. We reasoned that identifying cohorts of genes with shared features within each group would identify pathways, complexes, and mechanisms that regulate extracellular ATP levels. It is possible that some cell lysis could have contributed to increased extracellular ATP observed in certain strains. However, this was not investigated further.

![Screen identifying genes regulating ATP efflux. Extracellular adenosine triphosphate (ATP) levels of 4609 unique deletion strains are represented as a Log2 ratio of ATP level/cell. Values shown are the averages of three biological replicates for each deletion strain. Strains are rank ordered from left to right on the x-axis. The 5% of strains (n = 230) exhibiting the highest and lowest levels of extracellular ATP are indicated (green and red rectangles). These two sets constitute the High and Low ATP groups analyzed in this study.](161f1){#fig1}

To better understand how the genes within the High and Low Extracellular ATP groups are related, each group was queried individually for significantly enriched gene ontology (GO) terms ([Table 1](#t1){ref-type="table"}). GO analysis was carried out using the *Saccharomyces* Genome Database GO term finder tool and redundant categories with a greater than 2-fold enrichment were parsed with GO Trimming Software ([@bib19]).

###### Gene ontology (GO) enrichment in Low and High ATP groups

  **GO**           **GO Term**                                                             **ID**    **Hits**   **Bkg**   **Fold**   **p-Value**
  ---------------- ----------------------------------------------------------------------- --------- ---------- --------- ---------- -------------
  Low ATP Group                                                                                                                      
   BP              Mitochondrial translational initiation                                  0070124   5          5         19.9       2.3E-04
   BP              Intralumenal vesicle formation                                          0070676   5          5         19.9       2.3E-04
   CC              ESCRT-III complex                                                       0000815   4          4         19.9       1.0E-03
   BP              tRNA aminoacylation for mitochondrial protein translation               0070127   6          9         13.3       8.5E-04
   BP              tRNA aminoacylation                                                     0043039   9          14        12.8       2.1E-06
   BP              Ubiquitin-dependent protein catabolic process via MVB sorting pathway   0043162   12         19        12.6       5.5E-09
   MF              Proton-transporting ATP synthase activity, rotational mechanism         0046933   5          8         12.4       2.5E-03
   MF              Aminoacyl-tRNA ligase activity                                          0004812   7          12        11.6       7.8E-05
   CC              Mitochondrial large ribosomal subunit                                   0005762   18         35        10.2       7.5E-13
   BP              Mitochondrial translation                                               0032543   43         85        10.1       1.2E-31
   BP              Mitochondrial RNA metabolic process                                     0000959   9          18        9.9        4.3E-05
   CC              Endosome membrane                                                       0010008   11         24        9.1        9.3E-07
   CC              Mitochondrial ribosome                                                  0005761   28         62        9.0        1.1E-18
   CC              Mitochondrial small ribosomal subunit                                   0005763   9          23        7.8        1.3E-04
   CC              Mitochondrial matrix                                                    0005759   41         124       6.6        8.7E-22
   BP              Late endosome to vacuole transport                                      0045324   10         32        6.2        1.6E-03
   BP              Mitochondrion organization                                              0007005   63         229       5.5        5.3E-29
   BP              tRNA metabolic process                                                  0006399   16         81        3.9        1.3E-03
   MF              Structural constituent of ribosome                                      0003735   32         165       3.9        2.2E-09
   BP              Negative regulation of transcription from RNA polymerase II promoter    0000122   17         90        3.8        1.2E-03
   CC              Ribosomal subunit                                                       0044391   33         178       3.7        3.6E-09
   CC              Mitochondrial part                                                      0044429   65         371       3.5        1.2E-18
   CC              Endosome                                                                0005768   17         101       3.3        1.4E-03
   CC              Mitochondrial inner membrane                                            0005743   22         144       3.0        3.3E-04
   BP              Regulation of transcription from RNA polymerase II promoter             0006357   36         280       2.6        6.8E-05
   BP              Gene expression                                                         0010467   105        864       2.4        9.3E-19
   CC              Mitochondrion                                                           0005739   101        823       2.4        9.7E-19
   CC              Intracellular organelle lumen                                           0070013   59         482       2.4        2.9E-09
   BP              Cellular macromolecule biosynthetic process                             0034645   94         832       2.2        9.2E-14
   BP              Organelle organization                                                  0006996   90         848       2.1        3.6E-11
   BP              RNA metabolic process                                                   0016070   64         650       2.0        1.8E-05
  High ATP Group                                                                                                                     
   CC              GSE complex                                                             0034449   4          5         15.9       5.5E-03
   BP              Regulation of biological quality                                        0065008   32         286       2.2        8.1E-03
   CC              Nuclear lumen                                                           0031981   36         326       2.2        6.6E-04
   BP              Regulation of cellular macromolecule biosynthetic process               2000112   44         448       2.0        4.9E-03
   BP              Regulation of primary metabolic process                                 0080090   55         561       2.0        2.5E-04

Significantly enriched gene ontology (GO) categories for highest 5% and lowest 5% ATP groups are shown. "Hits" represents number of genes in each dataset (total = 230) with indicated GO ID; "Bkg" represents number of genes in the "background" yeast genome (total = 4609) with indicated GO ID; "Fold" represents fold enrichments of hits within a GO category as compared to chance expectation. ATP, adenosine triphosphate; BP, biological process; CC, cellular component; ESCRT, endosomal sorting complexes required for transport; tRNA, transfer ribonucleic acid; MVB, multivesicular bodies; MF, molecular function; GSE, Gap1 sorting in the endosome.

Representative deletion strains present as genes in enriched GO categories were subsequently retested using the same growth and assay conditions used in the primary screen. Extracellular ATP levels of all retested deletion strains are shown relative to extracellular ATP levels of the parent control ([Figure 2](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)).

![Retest of selected hits identified in the primary screen. Extracellular adenosine triphosphate (ATP) levels are shown for wild-type cells and strains deleted for genes encoding core components of the (A) ESCRT (endosomal sorting complex required for transport) complex, (B) EGO/GSE (exit from G~0~/Gap1 sorting in the endosome) complex, and (C) a group of EGO/GSE interacting proteins. n = 6 biological replicates in all cases. Bars indicate standard error values: \*\*\* p \< 0.005; \* p \< 0.05.](161f2){#fig2}

GO analyses of genes present in groups indicate that the genes found in the Low Extracellular ATP group share more annotations than those found in the High Extracellular ATP group. 76.1% of the genes in the Low ATP group are included in enriched GO terms as compared to 41.3% included in the High ATP group.

To illustrate the functional relationships within these groups, we generated interaction networks for each. This reveals additional relationships between genes that were not captured by GO analysis. Networks were constructed using YeastNet, a probabilistic functional gene network for yeast that incorporates experimental observations from DNA microarrays, physical protein interactions, genetic interactions, literature, and comparative genomics methods (<http://www.inetbio.org/yeastnet/>). In this analysis, 91.3% and 89.1% of the genes from the Low and High ATP groups, respectively, could be mapped into functional interaction networks ([Figure 3](#fig3){ref-type="fig"}) ([@bib22]).

![Interaction networks of genes in the High and Low ATP groups. Interaction networks of genes deleted in the High and Low Extracellular adenosine triphosphate (ATP) groups were assembled with data from the YeastNet large-scale interaction network. Relevant modules are shown within the (A) Low Extracellular ATP group (n = 147 nodes) and (B) High Extracellular ATP group (n = 123 nodes). Blue nodes represent respiration-deficient mutants and colored ovals define specific functional subnetworks as indicated in the Key. EGO/GSE, exit from G~0~/Gap1 sorting in the endosome.](161f3){#fig3}

These interaction networks illustrate the fact that genes in the Low ATP group are more closely related as compared to those in the High ATP group. The interaction network generated from the Low Extracellular ATP group shows a high degree of connectivity with an overall average of 2.03 edges/node, and comprises a unique module including 70% of the mapped Low ATP genes with only direct interactions, with an average of 2.19 edges/node. This module has two highly connected subnetworks representing components of two distinct cellular machines: the mitochondrial ribosome and the [e]{.ul}ndosomal [s]{.ul}orting [c]{.ul}omplexes [r]{.ul}equired for [t]{.ul}ransport (ESCRT) complex ([Figure 3A](#fig3){ref-type="fig"}). In contrast, the interaction network generated from the High Extracellular ATP group has an overall connectivity of 0.9 edges/node, comprises a unique module including 60% of mapped genes with an average of 1.48 edges/node, and does not appear to contain any large highly connected subnetworks. We do however observe a subnetwork comprised of four components of the GSE/EGO complex: [GTR1](http://www.yeastgenome.org/locus/S000004590/overview), [GTR2](http://www.yeastgenome.org/locus/S000003395/overview), [SLM4](http://www.yeastgenome.org/locus/S000000281/overview) and [MEH1](http://www.yeastgenome.org/locus/S000001715/overview) ([Figure 3B](#fig3){ref-type="fig"}). Representative genes present in specific networks modules were retested for ATP efflux as described above ([Figure 2](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)).

While the genes that influence extracellular ATP levels represent a wide range of cellular functions, pathways, and processes, GO and protein interaction analyses identified several common features within the datasets. We discuss observations derived from the analysis of the screen and their biological implications below.

Respiration mutants have decreased extracellular ATP levels {#s9}
-----------------------------------------------------------

The 5% of strains with the lowest levels of extracellular ATP were enriched for strains with deletions of nuclear-encoded mitochondrial genes. GO categories enriched significantly in the low ATP group included mitochondrial translation, tRNA aminoacylation, ATP Synthesis, and several cellular component categories associated with the mitochondria ([Table 1](#t1){ref-type="table"}). The functional interaction network for the Low ATP group also illustrates the relationship between deletion of mitochondrial components and low extracellular ATP levels ([Figure 3A](#fig3){ref-type="fig"}). Exemplifying this is a highly connected subnetwork of interacting proteins involved in mitochondrial translation ([Figure 3A](#fig3){ref-type="fig"}, red oval). Proteins in this subnetwork are primarily mitochondrial ribosomal proteins, suggesting that mitochondrial translation is critical for maintenance of wild-type levels of extracellular ATP. Retest data confirmed that several classes of mitochondrial mutants (representing GO categories: mitochondrial morphology, ATP synthase, mitochondrial ribosomal proteins) have decreased extracellular ATP levels ([Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)).

Mutants with defective mitochondria are known as "respiration deficient" mutants due to their inability to grow on nonfermentable carbon sources ([@bib31]). Given the enrichment of mitochondrial mutants in our Low ATP group, we reasoned that respiration deficient mutants would also be enriched in this group. This idea was confirmed by comparison of our results with a list of respiration-deficient mutants identified in a screen using a similar homozygous deletion library ([@bib12]). Our screen measured extracellular ATP levels in 293 of the 341 respiration-deficient strains identified by Dimmer and colleagues ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). Of these, 104 are found in the 5% of strains with the lowest extracellular ATP levels (n = 230), This represents a 7-fold enrichment over what would be expected by chance. By comparison, the High ATP group contains 11 of 230 respiration-deficient mutants. A hyper-geometric test indicates that this is not significantly different than a random distribution (p-value = 0.196).

These results indicate that mutants with compromised mitochondrial function (*i.e.*, respiration-deficient mutants) exhibit decreased extracellular ATP ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). While not unexpected, this indicates that our screen identified physiologically relevant pathways contributing to ATP production. Furthermore, it suggests that extracellular ATP is made primarily via oxidative respiration in the mitochondria, and is likely to be responsive to signals that regulate respiration. Finally, this finding suggests that cell signaling involving mitochondrial function may influence extracellular ATP levels, an idea we explore further below.

Extracellular ATP levels are regulated by vesicular sorting in the late endosome {#s10}
--------------------------------------------------------------------------------

Our data indicate that vesicular sorting in the late endosome is critical for the maintenance of extracellular ATP. In both the High and Low extracellular ATP groups, we identified components of machinery that regulate the trafficking of membrane proteins and associated vesicles through the endosome. Notably, components of both the ESCRT (Endosomal Sorting Complexes Required for Transport) and GSE ([Gap1](http://www.yeastgenome.org/locus/S000001747/overview) Sorting in the Endosome) complexes were represented among the deletions that exhibited anomalous ATP efflux.

The ESCRT complex is required for ATP efflux {#s11}
--------------------------------------------

The GO category "ESCRT-III complex" was highly enriched among the genes denoted the Low ATP group, with all four components being present ([Table 1](#t1){ref-type="table"}). The ESCRT machinery is comprised of four complexes that regulate the formation of multivesicular bodies (MVBs) in the late endosome. Membrane proteins targeted for degradation are sorted into MVBs and subsequently targeted for degradation in the vacuole. Inhibition of ESCRT function inhibits overall endosomal trafficking and results in an array of cellular phenotypes ([@bib29]). Analysis of genes in the Low ATP group revealed that mutants of the core components of the ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III complexes were all associated with low extracellular ATP. This resulted in additional enrichment of such GO terms as "intralumenal vesicle formation", "ubiquitin-dependent protein catabolic process via MVB sorting pathway", "endosome membrane" and "late endosome to vacuole transport" ([Table 1](#t1){ref-type="table"}). This relationship is also represented in a genetic interaction network as a highly connected subnetwork in the Low ATP group ([Figure 3A](#fig3){ref-type="fig"}). Proteins within this subnetwork are not reported to be respiration-deficient suggesting that mitochondrial defects are not driving diminished extracellular ATP in this group. This indicates that the Low ATP phenotype is driven by defects in the ATP efflux rather than ATP supply.

Retesting of strains with deletions in core components of all four ESCRT subcomplexes as well as strains null for ESCRT-interacting proteins confirms that the ESCRT complexes are required for wild-type ATP efflux. Remarkably, deletions in core components of any of the four ESCRT complexes resulted in significantly deceased extracellular ATP levels as compared to the parent strain (between a 1.4--2-fold reduction) ([Figure 2A](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Furthermore, six of the nine ESCRT-interacting protein deletions tested have significantly decreased extracellular ATP levels, indicating that they too are important for ATP efflux. This includes two mutants not scored as having decreased extracellular ATP in the primary screen ([Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)).

This analysis reveals that the ESCRT machinery and, thus, vesicle sorting in the late endosome is critical for ATP efflux. The late endosome is an important organelle for vesicle-mediated endo- and exocytosis and trafficking between intracellular compartments (*e.g.*, cell membrane, Golgi, vacuole). The ESCRT complexes are central to the recycling of proteins via multivesicular bodies (MVBs) that occur at late endosomes, and defects in this process are deleterious to global aspects of cellular vesicular trafficking ([@bib29]). ESCRT mutants, also known as "Class E vps" mutants, are characterized morphologically by enlarged late endosomes that accumulate cargo targeted for other parts of the cell ([@bib4]; [@bib27]). It would stand to reason that metabolites or proteins that are trafficked through the late endosome might also accumulate in this compartment in ESCRT mutants ([@bib4]). Thus, ESCRT mutants may be affecting ATP secretion by directly sequestering ATP in the late endosome and preventing its vesicle mediated-secretion.

The GSE complex negatively regulates ATP efflux {#s12}
-----------------------------------------------

Analysis of the strains with the highest levels of extracellular ATP (top 5%) revealed the enriched cellular component GO category "GSE complex" ([Table 1](#t1){ref-type="table"}). The GSE complex is a five-protein complex that is necessary for sorting of the [g]{.ul}eneral [a]{.ul}mino acid [p]{.ul}ermease [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) from the late endosome to the cell membrane upon aminoacid starvation. Although the molecular mechanism is unclear, cells null for GSE complex genes are unable to sort the [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) protein from the late endosome to the cell surface in response to amino acid signaling ([@bib15]). Four of the five genes that encode components of the GSE complex were present in the High ATP group ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)) suggesting that this complex inhibits ATP efflux.

Retesting confirmed that mutants lacking one of four components of the GSE complex (as observed in the primary screen) have a 1.5--2.7-fold increased extracellular ATP levels than the parent control strain ([Figure 2B](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Mutants carrying a deletion of the gene encoding the remaining 5th component of the GSE complex, *[LTV1](http://www.yeastgenome.org/locus/S000001626/overview)*, had a 1.2-fold decrease in extracellular ATP compared to the parent ([Figure 2B](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). [Ltv1](http://www.yeastgenome.org/locus/S000001626/overview)-HA has been shown to be the only GSE complex component that does not colocalize with the other components at the late-endosomal membrane, suggesting that [Ltv1](http://www.yeastgenome.org/locus/S000001626/overview) complex interaction may be transient or not associated with the function of the complex at the late endosome ([@bib15]). This is also consistent with a specific role for the late endosome in facilitating ATP efflux.

While the GSE complex is critical for promoting [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) localization to the cell surface upon amino acid-starvation, the ESCRT complex is important for the recycling of [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) from the cell membrane. Thus, our screen negatively correlates biochemical functions that favor trafficking of the [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) permease to the plasma membrane with extracellular ATP levels. In addition to the GSE complex, several proteins have been shown to be required for trafficking of [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) to the plasma membrane. These include [Sec13](http://www.yeastgenome.org/locus/S000004198/overview), [Lst4](http://www.yeastgenome.org/locus/S000001659/overview), [Lst7](http://www.yeastgenome.org/locus/S000003289/overview), and [Lst8](http://www.yeastgenome.org/locus/S000004951/overview) ([@bib28]). Mutations of any of these components prevent [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) from trafficking to the cell surface and instead promote its targeting to the vacuole for degradation ([Figure S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS1.pdf)). The recycling of [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) from the plasma membrane to the endosome requires polyubiquitination by the [Rsp5](http://www.yeastgenome.org/locus/S000000927/overview)/[Bul1](http://www.yeastgenome.org/locus/S000004888/overview)/[Bul2](http://www.yeastgenome.org/locus/S000004579/overview) complex, and efficient sorting within the late endosome requiring [Bro1](http://www.yeastgenome.org/locus/S000006005/overview), the deubiquitinase [Doa1](http://www.yeastgenome.org/locus/S000001696/overview), and the ESCRT complexes. Mutation of any of these components results in persistent localization of [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) at the plasma membrane ([@bib23]; [@bib24]; [@bib25]) ([Figure S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS1.pdf)).

To further examine the correlation between [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting and extracellular ATP levels, we asked whether other components of the [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting pathway can affect ATP efflux. Of the nonessential GSE-sorting components, *[lst4](http://www.yeastgenome.org/locus/S000001659/overview)∆* and *[lst7](http://www.yeastgenome.org/locus/S000003289/overview)∆* cultures were present in the High ATP group, while *[bul1](http://www.yeastgenome.org/locus/S000004888/overview)∆*, *[bro1](http://www.yeastgenome.org/locus/S000006005/overview)∆*, and *[doa4](http://www.yeastgenome.org/locus/S000002476/overview)∆* strains were present in the Low ATP group (*[SEC13](http://www.yeastgenome.org/locus/S000004198/overview)*, *[LST8](http://www.yeastgenome.org/locus/S000004951/overview)*, and *[RSP5](http://www.yeastgenome.org/locus/S000000927/overview)* are essential genes and, thus, not present in the deletion library used in the primary screen). Thus, mutants defective in [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting to the surface (GSE complex, *[LST7](http://www.yeastgenome.org/locus/S000003289/overview)*, and *[LST4](http://www.yeastgenome.org/locus/S000001659/overview)*) have high levels of extracellular ATP, while those deficient in [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) internalization (ESCRT complex and interactors, *[BUL1](http://www.yeastgenome.org/locus/S000004888/overview)*, *[BRO1](http://www.yeastgenome.org/locus/S000006005/overview)*, *[DOA4](http://www.yeastgenome.org/locus/S000002476/overview)*) have low levels of extracellular ATP.

Overall, retests confirmed that components promoting [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) localization to the plasma membrane resulted in increased ATP efflux, while those that promote [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) internalization result in decreased efflux. Both *[lst7](http://www.yeastgenome.org/locus/S000003289/overview)*∆ and *[lst4](http://www.yeastgenome.org/locus/S000001659/overview)*∆ cultures had 1.7-fold more extracellular ATP as compared to the parent control ([Figure 2C](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Components involved in [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) internalization seemed to have the most drastic effect on ATP efflux. Strains null for *[BRO1](http://www.yeastgenome.org/locus/S000006005/overview)* or *[DOA4](http://www.yeastgenome.org/locus/S000002476/overview)* had a 3.1- and 4.2-fold decrease in extracellular ATP as compared to the wild-type, and *[bul1](http://www.yeastgenome.org/locus/S000004888/overview)∆* cells had the lowest levels of ATP in our retest with a 6.6-fold decrease ([Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). The *[BUL1](http://www.yeastgenome.org/locus/S000004888/overview)* paralog *[BUL2](http://www.yeastgenome.org/locus/S000004579/overview)* did not affect extracellular ATP in either our screen or subsequent retests ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx) and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Finally, retesting of the *[gap1](http://www.yeastgenome.org/locus/S000001747/overview)∆* strain confirmed that the permease itself does not influence extracellular ATP levels ([Figure 2C](#fig2){ref-type="fig"} and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Together, these observations indicate that the vesicular sorting pathway responsible for trafficking [GAP1](http://www.yeastgenome.org/locus/S000001747/overview) has a critical role in ATP secretion.

[Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting is responsive to nitrogen availability ([@bib23]). We reasoned that nutrient signaling fluctuates during logarithmic growth and entry into stationary phase, and that this might affect ATP efflux. To further characterize the relationship between [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting and extracellular ATP in stationary phase, we measured extracellular ATP levels in cultures of wild-type, *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)*Δ (a GSE mutant), *[srn2](http://www.yeastgenome.org/locus/S000004109/overview)*Δ (an ESCRT-I mutant), and *[gap1](http://www.yeastgenome.org/locus/S000001747/overview)*Δ cells over a 96-hr time-course. Results of this experiment were consistent with observations from the primary screen and subsequent retests. Compared to background levels at the start of the time-course, wild-type cells exhibited a 7.5-fold increase in ATP levels 21 hr after inoculation ([Figure 4](#fig4){ref-type="fig"}). Cultures of the GSE mutant *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)∆* had significantly higher levels of extracellular ATP than the wild-type control at all time-points tested, supporting the idea that the GSE complex suppresses ATP secretion ([Figure 4](#fig4){ref-type="fig"}). *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)∆* cultures rapidly accumulated extracellular ATP to 9.2-fold above background within 8 hr of inoculation, and reached over 38-fold by 26 hr. At the same time-point, wild-type cultures had extracellular ATP levels of only 7.1-fold over initial media levels. By comparison, the ESCRT-I mutant *[srn2](http://www.yeastgenome.org/locus/S000004109/overview)*Δ showed decreased ATP efflux over the entire time-course ([Figure 4](#fig4){ref-type="fig"}). ATP levels were slow to rise in cultures of *[srn2](http://www.yeastgenome.org/locus/S000004109/overview)*Δ cells, peaking at 3.1-fold the initial readings at 26 hr and falling below initial media levels by the 72 hr time-point. As in the primary screen, we observed that *[gap1](http://www.yeastgenome.org/locus/S000001747/overview)*Δ cultures had similar levels of extracellular ATP as wild-type cultures at all time-points tested ([Figure 4](#fig4){ref-type="fig"}), indicating that this specific amino acid permease does not itself modulate extracellular ATP levels.

![Extracellular ATP levels measured over a 96-hr time-course. The levels of extracellular adenosine triphosphate (ATP) were measured in cultures of wild-type, *gtr1∆* (GSE mutant), *srn2∆* (ESCRT-I mutant), or gap1∆ cells over a 96-hr time-course. Values are normalized to ATP levels at time "0" within each strain. n = 6 biological replicates in all cases. Bars represent standard deviation. \*\*\* p \< 0.005; \*\* p \< 0.01. ESCRT-I, endosomal sorting complex required for transport I; GSE, Gap1 sorting in the endosome.](161f4){#fig4}

Our data indicate that cellular processes that regulate [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting between the plasma membrane and the endosome also mediate ATP efflux. Those components that promote [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) sorting to the cell surface ([Lst4](http://www.yeastgenome.org/locus/S000001659/overview), [Lst8](http://www.yeastgenome.org/locus/S000004951/overview), GSE complex) negatively regulate extracellular ATP concentrations. Conversely, proteins involved in recycling [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) from the surface (*e.g.*, [Bul1](http://www.yeastgenome.org/locus/S000004888/overview)) and sorting the permease into MVBs for degradation (*e.g.*, [Doa4](http://www.yeastgenome.org/locus/S000002476/overview), [Bro1](http://www.yeastgenome.org/locus/S000006005/overview), ESCRT complex) promote ATP efflux ([Figure S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS1.pdf)). Therefore, we conclude that this trafficking pathway is involved in sorting components critical for ATP efflux, and/or ATP itself, between the late endosome and the cell surface in a manner independent of [Gap1](http://www.yeastgenome.org/locus/S000001747/overview) function.

Signal transduction pathways affecting extracellular ATP levels {#s13}
---------------------------------------------------------------

Based upon our screening results, we hypothesized that ATP efflux is a highly regulated process responsive to nutrient signaling cues and mitochondrial function. Analysis of our screening data reveals two linked signaling pathways with integrated roles in regulating ATP efflux: EGO (Exit from G~0~) and TORC1 (target of rapamycin complex 1). Notably, these pathways are regulated by amino acid availability and mitochondrial function and result in a concerted transcriptional response regulated by the retrograde signaling pathway, which was also identified in our screen as important to maintain wild-type extracellular ATP concentrations ([@bib20]). This suggests an important link between extracellular ATP levels, mitochondrial function, and aminoacid signaling. Below, we discuss how these findings and how these signaling pathways may be critical to extracellular ATP levels.

The EGO complex regulates ATP efflux {#s14}
------------------------------------

Four of the five proteins that comprise the GSE complex are also components of the EGO complex. These are [Meh1](http://www.yeastgenome.org/locus/S000001715/overview), [Slm4](http://www.yeastgenome.org/locus/S000000281/overview), [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview), and [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview). [Meh1](http://www.yeastgenome.org/locus/S000001715/overview) and [Slm4](http://www.yeastgenome.org/locus/S000000281/overview) are important for stabilization, localization, and tethering the complex to the vacuolar membrane ([@bib36]). [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) and [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) are small GTPases homologous to mammalian RagA/B and RagC/D (respectively) that form a heterodimeric complex that regulates EGO function ([@bib36]). As in mammalian cells, an active EGO complex contains [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) (RagA/B) bound to GTP and [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) (RagC/D) bound to GDP ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)). The active EGO complex binds and activates TORC1. TORC1 is a highly conserved central regulator of cell physiology that couples growth and proliferation to nutrient signaling cues, including intracellular amino acid levels. Under growth conditions where amino acids are not limiting, the active EGO complex binds and activates TORC1 promoting translation, cell growth, and proliferation. When amino acids are limiting, the EGO complex is unable to activate TORC1, leading to inhibition of growth and activation of protein degradation, stress-responses, and nitrogen scavenging pathways ([@bib10]). Although the specific mechanism of TORC1 activation by the EGO complex has not been characterized in yeast, this signaling pathway is thought to be central to the cell's response to changes in intracellular amino acid levels ([@bib3]).

The key mechanism for regulation of Rag GTPases occurs through interaction with specific GTPase activating proteins (GAPs) and guanine nucleotide exchange factors (GEFs). In yeast, there is evidence that two different GAPs regulate the EGO complex, [Iml1](http://www.yeastgenome.org/locus/S000003899/overview) and [Lst7](http://www.yeastgenome.org/locus/S000003289/overview). [Iml1](http://www.yeastgenome.org/locus/S000003899/overview), which interacts with [Npr2](http://www.yeastgenome.org/locus/S000000788/overview) and [Npr3](http://www.yeastgenome.org/locus/S000001015/overview) in a complex called the Seh-association complex (SEAC), targets the active EGO complex and promotes [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) GTPase activity, resulting in inactivation of the complex ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)) ([@bib26]). The function of [Lst7](http://www.yeastgenome.org/locus/S000003289/overview) is less well characterized in yeast. The mammalian homolog of [Lst7](http://www.yeastgenome.org/locus/S000003289/overview), the Folliculin tumor suppressor (FLCN), promotes GTPase activity of RagC/D, the mammalian [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) homolog ([@bib32]). Although the mechanism of [Lst7](http://www.yeastgenome.org/locus/S000003289/overview) activity on [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) has not been described in yeast, genetic evidence suggests that [Lst7](http://www.yeastgenome.org/locus/S000003289/overview) and [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) function in the same pathway regulating the EGO complex ([@bib32]). Thus, by promoting [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) GTPase activity, [Lst7](http://www.yeastgenome.org/locus/S000003289/overview) would promote formation of an active EGO complex ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)). The GEF [Vam6](http://www.yeastgenome.org/locus/S000002235/overview) activates the EGO complex by facilitating the exchange of GDP for GTP on [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) ([@bib2]) ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)).

Our screen shows that deletion of any one of the EGO complex components results in increased extracellular ATP levels ([Figure 2B](#fig2){ref-type="fig"} and [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). Notably, the strain for the one gene unique to the GSE complex (*[ltv1](http://www.yeastgenome.org/locus/S000001626/overview)∆*) was not identified in our preliminary screen as affecting extracellular ATP levels, and exhibited a modest decrease in extracellular ATP levels in retest experiments ([Figure 2B](#fig2){ref-type="fig"}, [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx), and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Thus, *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)∆*, *[gtr2](http://www.yeastgenome.org/locus/S000003395/overview)∆*, *[meh1](http://www.yeastgenome.org/locus/S000001715/overview)∆*, and *[slm4](http://www.yeastgenome.org/locus/S000000281/overview)∆* mutants might be influencing ATP levels via their activity on TORC1, and not directly via vesicle sorting as described above.

Our initial screen also identified GAPs and GEFs that regulate the activity of the [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) and [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview). Strains lacking either *[NPR2](http://www.yeastgenome.org/locus/S000000788/overview)* or *[NPR3](http://www.yeastgenome.org/locus/S000001015/overview)*, components of the SEAC with [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) GAP activity, showed low levels of extracellular ATP in the initial screen ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)) and the retest showed that cultures of *[npr2](http://www.yeastgenome.org/locus/S000000788/overview)∆* cells had modest, yet significantly lower extracellular ATP levels than the wild-type control ([Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). This is consistent with the function of [Iml1](http://www.yeastgenome.org/locus/S000003899/overview)/[Npr2](http://www.yeastgenome.org/locus/S000000788/overview)/[Npr3](http://www.yeastgenome.org/locus/S000001015/overview) SEAC complex as a GAP for [Gtr1](http://www.yeastgenome.org/locus/S000004590/overview) ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)). We found that the putative [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) GAP, [Lst7](http://www.yeastgenome.org/locus/S000003289/overview), also affects extracellular ATP levels. In both the primary screen and subsequent retests, the *[LST7](http://www.yeastgenome.org/locus/S000003289/overview)* deletion strain showed elevated levels of extracellular ATP ([Figure 2C](#fig2){ref-type="fig"}, [Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx), and [Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)), supporting a model in which [Lst7](http://www.yeastgenome.org/locus/S000003289/overview) GAP activity promotes EGO complex activity via [Gtr2](http://www.yeastgenome.org/locus/S000003395/overview) ([Figure S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/FigureS2.pdf)).

Overall, our data indicates that the active EGO complex can suppress ATP efflux. In cells with mutations that stabilize the active complex (*[npr2](http://www.yeastgenome.org/locus/S000000788/overview)∆* and *[npr3](http://www.yeastgenome.org/locus/S000001015/overview)∆*), extracellular ATP is decreased. In cells that promote an inactive EGO complex (*[lst7](http://www.yeastgenome.org/locus/S000003289/overview)∆*, *[meh1](http://www.yeastgenome.org/locus/S000001715/overview)∆*, *[slm4](http://www.yeastgenome.org/locus/S000000281/overview)∆*, *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)∆*, or *[gtr2](http://www.yeastgenome.org/locus/S000003395/overview)∆*), extracellular ATP is elevated. Since the active EGO complex binds to and stimulates TORC1 activity ([@bib2]), we investigated whether EGO activation suppressed extracellular ATP levels via TORC1.

To test this, we measured extracellular ATP levels from cultures of wild-type cells that were treated with rapamycin during the last 4 hr of the 30-hr outgrowth. As rapamycin is an inhibitor of TORC1, we reasoned that ATP efflux would be elevated in rapamycin-treated cells. We found a dose dependent increase in extracellular ATP upon treatment with rapamycin. Treatment with 10 µg/ml rapamycin resulted in an approximately 3-fold increase in extracellular ATP as compared to control cultures ([Figure 5A](#fig5){ref-type="fig"}). We noted that rapamycin treatment at either 2 or 10 µg/ml elicited similar enhancement of extracellular ATP levels as seen in *[gtr1](http://www.yeastgenome.org/locus/S000004590/overview)∆* cells. These data are consistent with those showing that the EGO complex regulates ATP efflux via TORC1 ([Figure 5B](#fig5){ref-type="fig"}).

![Inhibition of TORC1 by rapamycin enhances ATP efflux. (A) Wild-type cells were grown for 26 hr and treated with vehicle only (0) or with rapamycin at indicated concentrations for 4 hr before extracellular adenosine triphosphate (ATP) was quantified. \*\*\* indicates p-value \< 0.005; \*\* indicates p-value \< 0.01. (B) Model of interaction between EGO, TORC1, and RTG transcriptional complex function in regulation of ATP production via mitochondrial function. Null mutants encoding proteins/protein complexes shown in green exhibit increased ATP efflux. Those shown in red exhibit decreased ATP efflux. EGO, exit from G~0~; RTG, retrograde; TORC1, TOR complex 1.](161f5){#fig5}

Regulation of ATP efflux by retrograde signaling {#s15}
------------------------------------------------

The mitochondrial retrograde (RTG) signaling cascade coordinates mitochondrial physiology and nuclear transcription to regulate cellular processes such as energy homeostasis, fatty acid metabolism, and apoptosis. The RTG pathway responds to changes in mitochondrial function and nutrient sensing pathways to modulate transcriptional responses to environmental conditions. Transcriptional activation by the RTG pathway is mediated by [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3, a heterodimer of two basic helix-loop-helix leucine-zipper proteins. Activation of the RTG pathway results in dephosphorylation and translocation of the [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3 complex from the cytoplasm to the nucleus ([@bib20]).

Central in the regulation of the [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3 localization is [Rtg2](http://www.yeastgenome.org/locus/S000003221/overview), a sensor of intracellular ATP levels and a transducer of amino acid signaling via TORC1 ([@bib11]; [@bib35]). When TORC1 is active, hyper-phosphorylated [Rtg3](http://www.yeastgenome.org/locus/S000000199/overview) is localized in the cytoplasm by phosphorylated [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) in complex with [Bmh1](http://www.yeastgenome.org/locus/S000000979/overview)/2 proteins. When TORC1 is inactive, [Rtg2](http://www.yeastgenome.org/locus/S000003221/overview) is thought to dephosphorylate [Rtg3](http://www.yeastgenome.org/locus/S000000199/overview) and bind hypo-phosphorylated [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) via an ATP-dependent mechanism ([@bib35]). This results in sequestration of [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) from the [Bmh1](http://www.yeastgenome.org/locus/S000000979/overview)/2 complex, facilitating ubiquitination and degradation of [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) by the [Grr1](http://www.yeastgenome.org/locus/S000003850/overview) SCF-ubiquitin ligase ([@bib30]). Thus [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview), [Rtg2](http://www.yeastgenome.org/locus/S000003221/overview), [Rtg3](http://www.yeastgenome.org/locus/S000000199/overview), and [Grr1](http://www.yeastgenome.org/locus/S000003850/overview) are positive regulators of the retrograde signaling pathway while TORC1, [Bmh1](http://www.yeastgenome.org/locus/S000000979/overview), [Bmh2](http://www.yeastgenome.org/locus/S000002506/overview), and [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) are negative regulators of this pathway.

Cells deleted for *[RTG1](http://www.yeastgenome.org/locus/S000005428/overview)*, *[RTG2](http://www.yeastgenome.org/locus/S000003221/overview)*, or *[RTG3](http://www.yeastgenome.org/locus/S000000199/overview)* exhibited low levels of extracellular ATP in the primary screen, suggesting that these genes promote ATP efflux ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). Conversely, *[bmh2](http://www.yeastgenome.org/locus/S000002506/overview)∆* cells produce high levels of extracellular ATP ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). Taken together, these data suggest that the RTG pathway regulates ATP efflux. Conversely, cultures of *[mks1](http://www.yeastgenome.org/locus/S000005020/overview)∆* cells had low concentrations of extracellular ATP ([Table S1](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS1.xlsx)). Retest of components in this pathway showed that cultures of either *[rtg1](http://www.yeastgenome.org/locus/S000005428/overview)∆* or *[rtg3](http://www.yeastgenome.org/locus/S000000199/overview)∆* showed a modest but significant decrease in levels of extracellular ATP as compared to wild-type controls (1.4- and 1.3-fold decrease, respectively). Cultures of *[rtg2](http://www.yeastgenome.org/locus/S000003221/overview)∆* or *[mks1](http://www.yeastgenome.org/locus/S000005020/overview)∆* cells, however, have extracellular ATP levels similar to the wild-type ([Table S2](http://www.g3journal.org/lookup/suppl/doi:10.1534/g3.115.023267/-/DC1/TableS2.xlsx)). Thus, while our data directly implicates the retrograde signaling transcription factor [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3 in the regulation of extracellular ATP, regulation of this phenotype by additional components of the RTG pathway remains to be more fully characterized.

Interaction between extracellular ATP-regulating components {#s16}
-----------------------------------------------------------

The results of our screen demonstrate that mitochondrial function, vesicular sorting, EGO-GSE/TORC1 amino acid signaling, and the retrograde response have integrated roles in regulating ATP efflux from *S. cerevisiae*. While we have discussed the relationships between genes found in our screen in the context of discrete mechanisms and pathways, there are considerable associations between them. For example, the role of the retrograde signaling [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3 transcription factor in promoting ATP efflux is consistent with our findings that inactivation of either EGO or TORC1 inhibition by rapamycin enhance ATP efflux, since the retrograde response is negatively regulated by TORC1 ([Figure 5B](#fig5){ref-type="fig"}) ([@bib21]). This association demonstrates interactions between amino acid signaling via the EGO complex and regulation of extracellular ATP, suggesting that these processes are coregulated.

Our data also indicate that functional mitochondria are required for high levels of extracellular ATP, as respiration-deficient mutants exhibit low efflux. The retrograde signaling pathway activates transcription of many nuclear-encoded mitochondrial genes, including those encoding components of the tricarboxylic acid cycle (TCA) ([@bib17]). Thus, activation of the retrograde response promotes increased respiration and, in turn, ATP production. A simple model representing the interaction between these findings predicts that the EGO/TORC1 complex regulates the RTG transcriptional response, which in turn promotes ATP production in the mitochondria ([Figure 5B](#fig5){ref-type="fig"}). While aspects of this pathway have been reported in other studies ([@bib11]; [@bib13]; [@bib21]; [@bib35]), the effect that this pathway has upon ATP efflux is a novel finding. Supporting this idea, intracellular ATP suppresses the RTG pathway by inactivating [Rtg2](http://www.yeastgenome.org/locus/S000003221/overview) and promoting suppression of the [Rtg1](http://www.yeastgenome.org/locus/S000005428/overview)/3 transcription factor by [Mks1](http://www.yeastgenome.org/locus/S000005020/overview) ([@bib35]). Furthermore, RTG pathway activation also promotes glutamate production in the mitochondria, which in turn can activate TORC1 ([@bib13]). Both these mechanisms represent feedback loops regulating the EGO/TORC1/RTG pathways that appear to regulate extracellular ATP levels ([Figure 5B](#fig5){ref-type="fig"}).

Maintaining intracellular ATP homeostasis is critical for proper cellular function ([@bib33]), and ATP efflux may also correlate with other physiological events that promote ATP production. Supporting this idea, wild-type cells have a drastic increase in ATP during the diauxic shift when cells switch from fermentation (with relatively lower ATP production) to oxidative phosphorylation (with relatively higher ATP production) ([Figure 4](#fig4){ref-type="fig"}). Mutations that enhance mitochondrial respiration via RTG signaling might also promote ATP production. Retrograde signaling activates the transcription of genes involved in the glyoxylate cycle, acetyl-CoA production, and the mitochondrial import of metabolites for amino acid synthesis ([@bib9]; [@bib17]). By activating the TCA cycle in cells that do not have mitochondrial defects, ATP synthesis is likely increased. Therefore, in conditions that deregulate RTG signaling suppression (*i.e.*, EGO mutants, TORC1 inhibition), extracellular ATP may be elevated as a result of increased ATP synthesis.

This study represents a critical step in identifying the cellular pathways and molecular mechanisms that regulate ATP efflux. Taken together, our screen has identified a central signaling pathway, responsive to both amino acid levels and mitochondrial function, that regulates extracellular ATP levels ([@bib21]). Furthermore, we report that vesicular sorting at the late endosome is also critical for extracellular ATP efflux. These results provide a basis for examining broader questions about the function and regulation of ATP efflux in yeast. It will also be of interest to determine whether and to what degree mechanisms regulating ATP efflux in yeast are conserved in mammalian systems in the contexts of metabolism, nutrient sensing, and purinergic signaling.
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